Pfizer Warns 2024 Revenue Could Fall, Weighed Down by Soft Demand for Covid Products


Updated Dec. 13, 2023 10:16 am ET

Pfizer shares tumbled Wednesday morning after the company said revenue could fall next year and issued 2024 guidance below analyst expectations.

Shares of the New York drugmaker fell by around 9% in early trading.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button